Applying multimodal dendrimers for prostate cancer theranostics

Area of Science:

• Polymer Chemistry
• Nanotechnology
• Oncology

Background:

• Dendrimers are highly branched, nanoscale polymers with unique architectures.
• Their precise structure and tunable surface groups make them suitable for biomedical applications.
• Conventional polymers have limitations in targeted drug delivery and diagnostics.

Purpose of the Study:

• To review recent advances in using dendrimers for prostate cancer theranostics.
• To highlight strategies for targeted imaging and treatment of prostate cancer.
• To discuss challenges hindering clinical translation of dendrimer-based agents.

Main Methods:

• Literature review of recent studies on dendrimer applications in prostate cancer.
• Analysis of strategies for dendrimer synthesis and functionalization for targeting.
• Evaluation of preclinical and clinical data on dendrimer-based theranostics.

Main Results:

• Dendrimers enable targeted delivery of imaging agents and therapeutics to prostate cancer cells.
• Functionalized dendrimers demonstrate potential for improved diagnostic accuracy and treatment efficacy.
• Several dendrimer-based approaches show promise in preclinical models.

Conclusions:

• Dendrimers offer a versatile platform for developing integrated diagnostic and therapeutic cancer agents.
• Targeted prostate cancer theranostics using dendrimers are advancing rapidly.
• Addressing challenges in synthesis, toxicity, and clinical validation is crucial for patient benefit.